首页> 外国专利> Combined Preparation comprising POLYPHASE estradiol and Dienogest for oral Therapy of dysfunctional uterine Bleeding with a Combined Oral Contraception

Combined Preparation comprising POLYPHASE estradiol and Dienogest for oral Therapy of dysfunctional uterine Bleeding with a Combined Oral Contraception

机译:口服避孕药含多聚雌二醇和Dienogest的联合制剂口服治疗功能障碍性子宫出血

摘要

Refers to a combined preparation of POLYPHASE Estradiol Valerate in combination with 17a - hidroxiestra cyanomethyl - 17 - beta - 4.9 - dien - 3-one (MEN) that contains: a) a first phase of two doses of estradiol 2,25mg Units; (b) a Second Phase of two groups of dose units that conti In: (i) 5 units of dose of a combination of 1.5 mg of estradiol and 2mg of Dienogest,(ii) 17 dose units and a combination of 1.5 mg of estradiol and 3mg of Dienogest; (c) a Third Phase 2 dose of estradiol 0,75mg Units; and (d) other Phase 2 dose units placebo; with which the POLYPHASE combined Preparation consists of a total of 28 dose units. This Preparation is helpful for oral contraception and oral Therapy of dysfunctional uterine bleeding
机译:指多聚戊二酸雌二醇戊酸酯与17a-氰基氰基甲基-17-β-4.9-二烯-3-one(MEN)的组合制剂,其包含:a)第一阶段,两剂雌二醇,2.25mg; (b)两组剂量单位的第二阶段,其连续:(i)5单位剂量的1.5 mg雌二醇和2mg Dienogest的组合,(ii)17剂量单位和1.5 mg雌二醇的组合和3mg的Dienogest; (c)雌二醇的第三阶段2剂量为0.75单位; (d)其他2期剂量单位的安慰剂; POLYPHASE与之合用的制剂包含28个剂量单位。该制剂有助于口服避孕药和口服治疗功能失调性子宫出血

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号